✦ LIBER ✦

Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran

✍ Scribed by Dr Ulf G. Eriksson, Susanne Johansson, Per-Ola Attman, Henrik Mulec, Lars Frison, Gunnar Vager, Ola Samuelsson

Book ID: 119926505
Publisher: Springer International Publishing AG
Year: 2003
Tongue: English
Weight: 159 KB
Volume: 42
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200342080-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, Preliminary Efficacy a

Pharmacokinetics, Preliminary Efficacy and Safety of Subcutaneous Melagatran and Oral Ximelagatran

✍ Dr David Bergqvist, Jan-Helge Solhaug, Lena Holmdahl, Ulf G. Eriksson, Magnus An 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 132 KB

Pharmacokinetics of Melagatran and the E

Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopaedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran

✍ Dr Ulf G. Eriksson, Jaap W. Mandema, Mats O. Karlsson, Lars Frison, Per Olsson G 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 209 KB

No Influence of Obesity on the Pharmacok

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

✍ Dr Troy C. Sarich, Renli Teng, Gary R. Peters, Maria Wollbratt, Robert Homolka, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

Influence of Renal Impairment on the Pha

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

✍ Dr Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dago Mazur 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 207 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid

✍ Gunnar Fager; Marie Cullberg; Maria Eriksson-Lepkowska; Lars Frison; Ulf G. Erik 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 311 KB

The pharmacodynamics and pharmacokinetic

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

✍ David Gustafsson; Margareta Elg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB